Veterinary Medicine Information website

Nobilis Reo 2177

Authorised
  • Avian reovirus, strain 2177, Live
Download as PDF

Product identification

Medicine name:
Nobilis Reo 2177
Active substance:
  • Avian reovirus, strain 2177, Live
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Avian reovirus, strain 2177, Live
    3.10
    log10 50% cell culture infectious dose
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Available only in Dutch
  • Glazen flacon (type I, Ph. Eur.), afgesloten met een halogeen rubberstop en een metalen felscapsule à 1000 doses.
  • Glazen flacon (type I, Ph. Eur.), afgesloten met een halogeen rubberstop en een metalen felscapsule à 1000 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 9940
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 2/03/2022
Download